ST. LOUIS — A St. Louis company announced a step forward with a blood-based test to screen for Alzheimer's disease. C2N Diagnostics, a company focused on diagnostic and therapeutic discovery, was started in 2007 by researchers from Washington ...
from Google Alert - health https://ift.tt/3eb1OCc
via IFTTT
0 comments:
Post a Comment